Peptide binding at the GLP-1 receptor

被引:38
作者
Mann, R. [1 ]
Nasr, N. [1 ]
Hadden, D. [1 ]
Sinfield, J. [1 ]
Abidi, F. [1 ]
Al-Sabah, S. [1 ]
de Maturana, R. Lopez [1 ]
Treece-Birch, J. [1 ]
Willshaw, A. [1 ]
Donnelly, D. [1 ]
机构
[1] Univ Leeds, Fac Biol Sci, LIGHT Labs, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England
关键词
exendin-4 (EX-4); glucagon-like peptide receptor 1 (GLP1-R); G-protein-coupled receptor (GPCR); peptide binding; Type; 2; diabetes;
D O I
10.1042/BST0350713
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The receptor for GLP-1 [glucagon-like peptide-1-(7-36)-amide] is a member of the 'Family B' of GPCRs (Gprotein-coupled receptors) comprising an extracellular N-terminal domain containing six conserved cysteine residues (the N-domain) and a core domain (or J-domain) comprising the seven transmembrane helices and interconnecting loop regions. According to the two-domain model for peptide binding, the N-domain is primarily responsible for providing most of the peptide binding energy, whereas the core domain is responsible for binding the N-terminal region of the peptide agonists and transmitting the signal to the intracellular G-protein. Two interesting differences between the binding properties of two GLP-11 receptor agonists, GILP-1 and EX-4 (exendin-4), can be observed. First, while GLP-1 requires its full length to maintain high affinity, the eight N-terminal residues of EX-4 can be removed with little reduction in affinity. Secondly, EX-4 (but not GLP-1) can bind to the fully isolated N-domain of the receptor with an affinity matching that, of the full-length receptor. in order to better understand these differences, we have studied the interaction between combinations of full-length or truncated ligands with full-length of truncated receptors.
引用
收藏
页码:713 / 716
页数:4
相关论文
共 15 条
[1]   The positive charge at Lys-288 of the glucagon-like peptide-1 (GLP-1) receptor is important for binding the N-terminus of peptide agonists [J].
Al-Sabah, S ;
Donnelly, D .
FEBS LETTERS, 2003, 553 (03) :342-346
[2]   A model for receptor-peptide binding at the glucagon-like peptide-1 (GLP-1) receptor through the analysis of truncated ligands and receptors [J].
Al-Sabah, S ;
Donnelly, D .
BRITISH JOURNAL OF PHARMACOLOGY, 2003, 140 (02) :339-346
[3]   In vitro folding, functional characterization, and disulfide pattern of the extracellular domain of human GLP-1 receptor [J].
Bazarsuren, A ;
Grauschopf, U ;
Wozny, M ;
Reusch, D ;
Hoffmann, E ;
Schaefer, W ;
Panzner, S ;
Rudolph, R .
BIOPHYSICAL CHEMISTRY, 2002, 96 (2-3) :305-318
[4]   Full activation of chimeric receptors by hybrids between parathyroid hormone and calcitonin - Evidence for a common pattern of ligand-receptor interaction [J].
Bergwitz, C ;
Gardella, TJ ;
Flannery, MR ;
Potts, JT ;
Kronenberg, HM ;
Goldring, SR ;
Juppner, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (43) :26469-26472
[5]   The isolated N-terminal domain of the glucagon-like peptide-1 (GLP-1) receptor binds exendin peptides with much higher affinity than GLP-1 [J].
de Maturana, RL ;
Willshaw, A ;
Kuntzsch, A ;
Rudolph, R ;
Donnelly, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (12) :10195-10200
[6]   Met-204 and Tyr-205 are together important for binding GLP-1 receptor agonists but not their N-terminally truncated analogues [J].
de Maturana, RL ;
Treece-Birch, J ;
Abidi, F ;
Findlay, JBC ;
Donnelly, D .
PROTEIN AND PEPTIDE LETTERS, 2004, 11 (01) :15-22
[7]   The glucagon-like peptide-1 receptor binding site for the N-terminus of GLP-1 requires polarity at Asp198 rather than negative charge [J].
de Maturana, RL ;
Donnelly, D .
FEBS LETTERS, 2002, 530 (1-3) :244-248
[8]   Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes [J].
DeFronzo, RA ;
Ratner, RE ;
Han, J ;
Kim, DD ;
Fineman, MS ;
Baron, AD .
DIABETES CARE, 2005, 28 (05) :1092-1100
[9]   NMR structure and peptide hormone binding site of the first extracellular domain of a type B1 G protein-coupled receptor [J].
Grace, CRR ;
Perrin, MH ;
DiGruccio, MR ;
Miller, CL ;
Rivier, JE ;
Vale, WW ;
Riek, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (35) :12836-12841
[10]   The glucagon-like peptides [J].
Kieffer, TJ ;
Habener, JL .
ENDOCRINE REVIEWS, 1999, 20 (06) :876-913